智通财经APP讯,佰金生命科学(01466)发布公告,于2025年3月18日,公司拟向认购人发行合共6535.94万股,相当于经配发及发行认购股份扩大后公司已发行股本约8.46%。认购价为每股认购股份0.48港元,较3月18日收市价每股0.5港元折让约4.00%。
认购事项的所得款项总额将约为3137.3万港元。认购事项的所得款项净额估计约为3127.3万港元。公司拟将认购事项的所得款项净额用作集团的一般营运资金。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.